A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia

BACKGROUND: Hyperkalemia is associated with many chronic diseases and renin-angiotensin-aldosterone system inhibitor therapy. Sodium zirconium cyclosilicate (SZC), an oral, highly selective cation-exchanger, is approved for the treatment of hyperkalemia. METHODS: This phase 3, multicenter, open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashihara, Naoki, Yamasaki, Yoshimitsu, Osonoi, Takeshi, Harada, Hiromasa, Shibagaki, Yugo, Zhao, June, Kim, Hyosung, Yajima, Toshitaka, Sarai, Nobuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880936/
https://www.ncbi.nlm.nih.gov/pubmed/33098526
http://dx.doi.org/10.1007/s10157-020-01972-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880936/
https://www.ncbi.nlm.nih.gov/pubmed/33098526
http://dx.doi.org/10.1007/s10157-020-01972-y

Ejemplares similares